he pharmaceutical microbiology industry has seen many changes during the progression into the 21st century. With advances in rapid microbiological methods, revisions being made to regulations in the industry, enhanced knowledge of the human microbiome, and novel testing methods, this industry is ever expanding. In fact, the value of the rapid microbiology testing market is expected to reach USD 6.2 Billion by 2022, expanding at a CAGR of 7.3% from 2016 to 2022. This is the 8^th year of a conference which is continually run by SMi and which has been very successful over the past few years.

Developing on last years’ success, Pharmaceutical Microbiology UK 2019 will bring together industry experts to discuss and analyse the latest advancement and challenges within pharmaceutical microbiology. Discover how you can keep up with regulatory changes and maintain the utmost efficiency during production and testing.

Event Hashtag: #PharmaMicro

At the 8th Annual Pharmaceutical Microbiology Conference, you will gain insight into:

• Challenges in development of a contamination control strategy for different product types
• A series of learning experiences within contamination from Boehringer Ingelheim
• The use of vaporized hydrogen peroxide bio-decontamination technology in microbiology contamination control
• Case studies in deinococcus and fungal and bacterial spores in cleanrooms
• Influence of temperature of incubation on results of microbiological environmental monitoring
• Risk mitigation strategies for animal-derived raw materials

FEATURED SPEAKERS INCLUDE:

• Alexander Stoll, VP Competence Center Microbiology & Aseptic Technique Quality Management, Fresenius Kabi
• Di Morris, Senior Manager, Team Leader, Vaccines Quality Audit, GSK
• Marine Marius, Scientist, Analytical Research & Development Europe, Sanofi Pasteur
• Philippe Dutot, Sterility Assurance Specialist, Novo Nordisk
• Renate Rosengarten, Professor and Chair of Bacteriology and Hygiene, University of Veterinary Medicine Vienna
• Thierry Bonnevay, Microbiology Platform Head, Analytical Research and Development, Sanofi Pasteur
• Tim Eaton, Sterile Manufacturing Specialist, AstraZeneca
  

KEY TOPICS FOR 2018 INCLUDE:

• Rapid Microbial Methods
• Revision of Annex 1 and impact on pharmaceutical microbiology
• Contamination control strategies and case studies
• Mycoplasma detection, prevention and control
• Future of endotoxin testing in pharmaceutical industries
• Strengths and weaknesses of vaporized Hydrogen peroxide as a bio-contamination control agent
• Mold contamination control
• Influence of temperature of incubation on results of microbiological environmental monitoring
  

WHO SHOULD ATTEND

Senior Microbiologist, Lead Scientist, Laboratory Manager, QA Specialist Drug Substance External Manufacturer, Business Development Manager – Testing, Pharmaceutical Microbiology Consultant, Higher Pharmacopoeia Scientist, Analytical Standards Specialist

SPONSORED BY:
GOLD SPONSOR: DuPont
SPONSORS: Mettler Toledo, bioMérieux, Copan Group & Fujifilm

CHAIRED BY:
James Drinkwater, Chairman, Pharmaceutical & Healthcare Sciences Society
Olivier Chancel, Sterility and Aseptic Process Assurance, Expert, Boehringer Ingelheim

The pharmaceutical microbiology industry has seen many changes during the progression into the 21st century. With advances in rapid microbiological methods, revisions being made to regulations in the industry, enhanced knowledge of the human microbiome, and novel testing methods, this industry is ever expanding.

In fact, the value of the rapid microbiology testing market is expected to reach USD 6.2 Billion by 2022, expanding at a CAGR of 7.3% from 2016 to 2022. This is the 8th year of a conference which is continually run by SMi and which has been very successful over the past few years.

Developing on last years’ success, Pharmaceutical Microbiology UK 2019 will bring together industry experts to discuss and analyse the latest advancement and challenges within pharmaceutical microbiology. Discover how you can keep up with regulatory changes and maintain the utmost efficiency during production and testing.

Event Hashtag: #PharmaMicro

At the 8th Annual Pharmaceutical Microbiology Conference, you will gain insight into:

Challenges in development of a contamination control strategy for different product types
A series of learning experiences within contamination from Boehringer Ingelheim
The use of vaporized hydrogen peroxide bio-decontamination technology in microbiology contamination control Case studies in deinococcus and fungal and bacterial spores in cleanrooms Influence of temperature of incubation on results of microbiological environmental monitoring Risk mitigation strategies for animal-derived raw materials

FEATURED SPEAKERS INCLUDE:

• Alexander Stoll, VP Competence Center Microbiology & Aseptic Technique Quality Management, Fresenius Kabi
• Di Morris, Senior Manager, Team Leader, Vaccines Quality Audit, GSK
• Marine Marius, Scientist, Analytical Research & Development Europe, Sanofi Pasteur
• Philippe Dutot, Sterility Assurance Specialist, Novo Nordisk
• Renate Rosengarten, Professor and Chair of Bacteriology and Hygiene, University of Veterinary Medicine Vienna
• Thierry Bonnevay, Microbiology Platform Head, Analytical Research and Development, Sanofi Pasteur
• Tim Eaton, Sterile Manufacturing Specialist, AstraZeneca

KEY TOPICS FOR 2018 INCLUDE:

• Rapid Microbial Methods
• Revision of Annex 1 and impact on pharmaceutical microbiology
• Contamination control strategies and case studies
• Mycoplasma detection, prevention and control
• Future of endotoxin testing in pharmaceutical industries
• Strengths and weaknesses of vaporized Hydrogen peroxide as a bio-contamination control agent
• Mold contamination control
• Influence of temperature of incubation on results of microbiological environmental monitoring

WHO SHOULD ATTEND
Senior Microbiologist, Lead Scientist, Laboratory Manager, QA Specialist Drug Substance External Manufacturer, Business Development Manager – Testing, Pharmaceutical Microbiology Consultant, Higher Pharmacopoeia Scientist, Analytical Standards Specialist.

SPONSORED BY:

GOLD SPONSOR: DuPont
SPONSORS: Mettler Toledo, bioMérieux, Copan Group & Fujifilm 

CHAIRED BY:
James Drinkwater, Chairman, Pharmaceutical & Healthcare Sciences Society
Olivier Chancel, Sterility and Aseptic Process Assurance, Expert, Boehringer Ingelheim

Digital Strategies Delivering Real Results. A One Day Conference & Networking Event. 31 Pharma Brands Including GSK, Pfizer, Merck, Teva & ABPI Unveil The Hottest Digital Marketing Innovations In Just 1 Day!

Optimise HCP-Focused, Patient-Centric Digital Strategies Compliantly With New Tech Trends, Innovative Social & Savvy Integrated Campaigns For Engaging, Customer-Centric, Multi-Channel Digital Pharma Marketing Strategies

Monetise Data & Customer Insights, Transform Cultures, Embed Digital Innovation, Prove ROI, Empower The Sales-Force & Deliver Results – Get Inspired By Today’s Digital Disruptors & Innovators. A One-Day Brand-Led Conference & Networking Event, 30th January 2019, One Great George Street, Central London & Post-Conference Multi-Channel Excellence Day, 31st January 2019, Asia House, Central London.

Cell Culture in an important tool for research and development within the life science industry. Over the past few years, 3D Cell Culture has gained momentum within the pharmaceutical industry due to the benefits that this model offers over conventional cell culture methods.

3D cell culture enables cells to grow and interact with their surroundings in all three dimensions, better mimicking the in-vivo conditions in which the cells are naturally present. This enhances the ability for scientists to study basic biological mechanisms such as cell number monitoring, cell viability, proliferation and morphology. 3D cell cultures also have greater stability and longer life spans.

Researchers globally are realizing the potential of 3D cell culture for various applications, including testing and discovering new drugs to treat cancer, organ-on-chip models to study the human physiology in an organ specific context, and 3D cell printing to produce organ models. Therefore, this market is likely to grow over the next few years and is in fact projected to reach USD 1.7 Million by 2022, growing at a CAGR of 20.3% between 2017-2022. Growth in this market is also driven by global factors such as a need for alternative methods to animal resting, funding from governments and private entities and technological advancements in the field.

At the 3D Cell Culture Conference in February, we will look at the latest developments in the 3D Cell Culture field. Participants will have the opportunity to network with industry experts, gain insight into how the pharmaceutical industry is utilizing 3D Cell Culture technologies to enhance research and development, discuss the potential for novel in-vitro cell culture models to replace animal models, and discover novel 3D cell culture systems, organ-on-chip, 3D imaging of organoids and other technologies in development.

Event Hashtag: #SMi3DCellCulture

FEATURED SPEAKERS INCLUDE:
GUEST SPEAKER:
Bill Mattes, Director, Division of Systems Biology, FDA

SPEAKERS INCLUDE:

• Asli Akidil, Cell and Molecular Scientist, AstraZeneca
• Gary Allenby, Business Development Director and Chief Scientific Officer, Aurelia Biosciences
• Jason Ekert, Head of Complex In Vitro Models, GSK
• Philip Hewitt, UK and Eurotox Registered Toxicologist, Head of Early Investigative Technology, Merck
• Stefan Kustermann, Lab Head, Investigative Safety, Roche
• Veronique Barban, Expert Virology, Research and Nonclinical Safety Department, Sanofi Pasteur

KEY TOPICS FOR 2019 INCLUDE:

• Organ-on-chip technologies and their applications in the pharmaceutical industry
• Panel discussion on whether 3D Cell Culture will replace animal models
• Determining the predictive validity of 3D models and achieving standardization for preclinical testing
• Global developments in 3D Cell Culture and how this exponential growth will impact researchers
• Several novel techniques for imaging of 3D Cell Cultures
• Development of 3D eye models for early assessment of retinal toxicity
• Musculoskeletal regeneration harnessing preclinical models for tissue repair

View the full agenda: www.3D-cellculture.com/hhglobal

India’s No. 1 Trade Fair for Hospitals, Health Centres and Clinics

5 reasons to attend MEDICAL FAIR INDIA

Business: MEDICAL FAIR INDIA is India’s no. 1 exhibition and conference for healthcare, which act as a platform where connections are made and business relationships are nurtured.
Positioning: With participation from over 20 countries, MEDICAL FAIR INDIA provides an opportunity to position your brand among competitors and further increase your level of visibility.
Trends: MEDICAL FAIR INDIA is well known for its ability to detect trends and respond to market impulse.
Solutions: Find diverse solutions to your diverse healthcare needs.
Innovations: Explore how the latest digital technologies and new approaches shaping healthcare.

Indian Healthcare is experiencing a new wave of opportunity
The Indian healthcare sector is diversifying and opportunities are emerging in every segment. The following emerging trends are changing course of the industry:

The change in the government’s role from provide to payer has expanded the financial risk protection coverage to the mariginalised. Private sector partnership through health PPPs are gradually gaining acceptance, thereby improving access to care. The significant demand-supply mismatch has led healthcare to emerge as an attractive sector for PE investements.

Conference Series extends its welcome to the conference 5th International Conference on Neuro-Oncology and Brain Tumor during February 27-28, 2019 Seoul, South Korea with a theme “Future challenges and the latest Impact Factor for Neuro-Oncology and Brain Tumor”. Conference Series through its Open Access Initiative is committed to make genuine and reliable contributions to the scientific community.

Conference Series llc LTD Organizes 1000+ Conferences Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board members. Neuro-Oncology 2019, Conference will focus on educational research directed toward its impact on clinical outcomes, through oral and poster presentations, educational workshop sessions, and influential plenary presentations.

Neuro-Oncology 2019 is a perfect platform to find out how Neuro-Oncology research innovations helpful to the Medical, Health and human society. Conference will mainly focus on the trending topics during presentations of the two-day event, which reflect current education, research, developments and innovations internationally in the field of Neuro-Oncology and medical sectors.